Statute Details
- Title: Health Products (Supply of Medical Devices — Exemption) Order 2022
- Act Code: HPA2007-S688-2022
- Type: Subsidiary Legislation (SL)
- Authorising Act: Health Products Act 2007
- Enacting Authority: Health Sciences Authority (HSA)
- Enacting Formula Power: Section 70 of the Health Products Act 2007
- Commencement: 1 September 2022
- Legislative Number: No. S 688
- Publication/Instrument: SL 688/2022
- Key Provisions: Section 1 (citation and commencement); Section 2 (retail supply exemption); Section 3 (revocation)
- Revoked Instrument: Health Products (Import, Wholesale and Supply of Medical Devices — Exemption) Order 2020 (G.N. No. S 78/2020)
What Is This Legislation About?
The Health Products (Supply of Medical Devices — Exemption) Order 2022 is a targeted regulatory instrument made under the Health Products Act 2007. In plain terms, it creates a limited exemption from a specific statutory requirement relating to the supply of medical devices—specifically, supply by retail—by certain persons.
The Order is not a general “licensing” or “registration” regime. Instead, it addresses a narrow compliance issue: it clarifies that section 15(1) of the Health Products Act 2007 does not apply to the retail supply of specified categories of medical devices, provided those devices were imported before a defined cut-off date (1 September 2022). This is a classic “transitional” or “stock” exemption: it allows existing inventory to be sold without triggering the full force of the usual legal requirement.
From a practitioner’s perspective, the Order matters because it affects how businesses (such as retailers, distributors, and importers with retail channels) manage regulatory obligations for medical devices that were imported during an earlier period—most likely in the context of heightened demand for protective equipment and related health products.
What Are the Key Provisions?
Section 1: Citation and commencement establishes the formal identity of the instrument and when it takes effect. The Order is cited as the “Health Products (Supply of Medical Devices — Exemption) Order 2022” and comes into operation on 1 September 2022. For compliance purposes, this date is crucial because the exemption in section 2 is tied to whether the medical devices were imported before that date.
Section 2: Exemption in relation to supply by retail is the core operative provision. It states that section 15(1) of the Health Products Act 2007 does not apply to the supply by retail by a person of any of the listed medical devices, if those devices were imported before 1 September 2022.
The listed devices are:
- (a) a particulate respirator
- (b) any protective gear
- (c) a surgical mask
- (d) a thermometer for measuring human body temperature
In practical terms, section 2 provides a carve-out for retail supply of these categories of products. The exemption is conditional on both (i) the type of medical device and (ii) the import timing. If a retailer supplies such devices that were imported before 1 September 2022, section 15(1) is not applicable. If the devices were imported on or after 1 September 2022, the exemption would not apply, and the general requirements under section 15(1) would presumably govern.
Section 3: Revocation revokes the earlier exemption order: Health Products (Import, Wholesale and Supply of Medical Devices — Exemption) Order 2020 (G.N. No. S 78/2020). This means that the 2020 instrument no longer has effect. The revocation is significant because it indicates a regulatory shift: the earlier exemption framework is replaced (at least for the relevant retail supply aspect) by the 2022 Order.
Although the extract does not reproduce the full text of section 15(1) of the Health Products Act 2007, the structure of the Order makes clear that section 15(1) imposes some legal obligation that would otherwise apply to retail supply. The exemption order removes that obligation for the specified devices and the specified import period. For counsel, the key task is to identify what section 15(1) requires—whether it relates to authorisation, approval, licensing, or compliance with supply conditions—and then map the exemption to the client’s product and supply chain facts.
How Is This Legislation Structured?
This Order is structured in a straightforward, three-section format typical of subsidiary legislation that performs a narrow regulatory function:
- Section 1 sets out the citation and commencement date.
- Section 2 provides the substantive exemption, specifying (i) the provision being exempted from (section 15(1) of the Act), (ii) the activity covered (supply by retail), (iii) the categories of medical devices, and (iv) the temporal condition (imported before 1 September 2022).
- Section 3 revokes the earlier exemption order from 2020.
There are no schedules or complex procedural steps in the extract. The operative content is concentrated in section 2, which is drafted to be easily applied to inventory and supply transactions.
Who Does This Legislation Apply To?
The exemption applies to “the supply by retail by a person” of the specified medical devices. In practice, this will include retailers who sell these products directly to consumers, and potentially any business entity that qualifies as a “person” under the Health Products Act 2007 and is engaged in retail supply.
The exemption is also fact-dependent. A retailer can rely on the exemption only if the devices were imported before 1 September 2022. Therefore, the practical scope is determined by documentary evidence and supply chain records: import invoices, customs declarations, purchase orders, and inventory records will be important to establish the import date.
Why Is This Legislation Important?
This Order is important because it provides legal certainty for retail supply of certain medical devices during a transition period. Without such an exemption, retailers might face compliance risks—such as the potential applicability of section 15(1) requirements to their sales—if those requirements were not designed to accommodate pre-existing stock.
From a compliance and enforcement standpoint, the Order reduces the likelihood of inadvertent breaches. It allows businesses to continue selling specified categories of medical devices that were already imported before the commencement date, even if the regulatory landscape changed with the revocation of the 2020 exemption order.
For practitioners advising clients, the key practical impacts are:
- Inventory classification: Clients must confirm whether their products fall within the listed categories (particulate respirators, protective gear, surgical masks, and thermometers for measuring human body temperature). Product labelling, intended use, and technical specifications may be relevant to classification.
- Import timing evidence: The exemption hinges on whether the devices were imported before 1 September 2022. Clients should maintain import documentation and reconcile it with current stock.
- Supply channel analysis: The exemption is limited to supply by retail. If a client supplies through wholesale channels or other non-retail arrangements, the exemption may not cover those activities.
- Regulatory transition management: The revocation of the 2020 Order means clients should not assume that earlier exemptions continue. They must check the current legal instrument applicable to their supply activities.
Finally, the Order illustrates how Singapore uses subsidiary legislation to calibrate regulatory obligations in response to changing public health needs and market conditions. Even though the instrument is narrow, it can have significant commercial consequences for retailers holding stock of protective equipment and related devices.
Related Legislation
- Health Products Act 2007 (in particular, section 15(1) and the regulation-making power in section 70)
- Health Products (Import, Wholesale and Supply of Medical Devices — Exemption) Order 2020 (G.N. No. S 78/2020) — revoked by section 3 of this Order
Source Documents
This article provides an overview of the Health Products (Supply of Medical Devices — Exemption) Order 2022 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.